Panaji
BioAsia, Asia’s biggest technology and bio-business platform, announced its partnership with PM Modi's ambitious 'Make in India' initiative and will be holding an event in Hyderabad from February 8 to Februaru 10, 2016.
The partnership will make BioAsia the only BioPharma event to associate with this ambitious initiative of the Government of India. ‘Make in India’ partnership will also enhance the level of the impact of the deliberations at the event, given that the relevant policy makers will be attendance at the event.
Under this context, CEO Conclave of this edition of BioAsia will focus on “Make in India - Flavors of policy change”. The conclave will elicit thought provoking discussions on the opportunities and challenges for the sector under the Make in India program, besides proposing various policy measures that can accelerate the growth of life sciences sector in India.
Prominent industry leaders and policy makers including the likes of Dr. V K Subburaj, IAS, secretary to GoI, department of pharmaceuticals, Rogerio Ribeiro, SVP & head, emerging markets, GSK, RanjitShahani, vice chairman & managing director, Novartis India Limited among others will participate in the conclave. The event will also see the unveiling of BioAsia-KPMG thought leadership report on Make in India for the biotech sector.
